When was Fore Genomics founded?

Fore Genomics was founded in 2021.

Where is Fore Genomics located?

Fore Genomics is headquartered in San Diego, United States.

Who is the current CEO of Fore Genomics?

Matt Pelo of Fore Genomics. They have also founded 1 company.

How many employees does Fore Genomics have?

As of Aug 31, 2026, the latest employee count at Fore Genomics is 10.

Where does Fore Genomics rank among its competitors?

Fore Genomics ranks 339th amongst 547 active competitors, of which 83 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was GenePlanet, which secured an undisclosed amount in Jul, 2026.

Who are the top competitors of Fore Genomics?

Fore Genomics' top competitors include MyHeritage, 23andMe and Helix. Among them, GenePlanet secured the most recent funding round in July, 2026.

Fore Genomics - 2026 Company Profile, Team & Competitors

Company Details

Provider of genetic screening to identify risks and personalize medication. The company offers at-home kits for sample collection and sequencing in an accredited lab. Reports for conditions and medication response are provided by licensed genetic counselors. The screening covers treatable conditions and provides insights on medications.

Website: www.foregenomics.com/
Social
Email ID: *****@foregenomics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2021

Location

San Diego, United States

Stage

Unfunded

Ranked

339^th among 547 active competitors

Employee Count

10 as on Aug 31, 2026

Similar Companies

MyOme & 463 more

View Fore Genomics' full profile

Fore Genomics has not raised any funding rounds yet.

The founders of Fore Genomics are Kyle Schramer and Matt Pelo. Matt Pelo is the CEO of Fore Genomics.

Here are the details of Fore Genomics' key team members:

Kyle Schramer: Co-Founder of Fore Genomics.
Matt Pelo: Co-Founder & CEO of Fore Genomics.

View details of Fore Genomics's Founder profiles and Board Members

Fore Genomics' employee count trend

Fore Genomics has 10 employees as of Aug 26. Here is Fore Genomics's employee count trend over the years:

Uncover Fore Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Fore Genomics include MyHeritage, 23andMe and Helix. Here is the list of Top 10 competitors of Fore Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MyHeritage 2003, Yehud (Israel), Acquired	Provider of tools for creating family trees and exploring ancestry	$49M	Index Ventures, Bessemer Venture Partners ... & 12 others	77/100
2nd	23andMe 2006, Sunnyvale (United States), Acquired	Provider of genetic test solutions to study ancestry, genealogy, and inherited traits	$944M	Fidelity Investments, Google Ventures & 35 others	77/100
3rd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
4th	Color 2013, Burlingame (United States), Series E	Provider of end-to-end Virtual clinic offering cancer-based solutions	$491M	General Catalyst, T. Rowe Price & 46 others	66/100
5th	Nucleus Genomics 2021, Manhattan (United States), Series A	Provider of genetic testing kits for rare variant analysis	$32M	Founders Fund, Giant Step Capital & 28 others	62/100
6th	MyOme 2017, San Carlos (United States), Series B	Provider of a platform for gene analysis to determine genetic diseases and drug response	$36M	Healthcare Ventures, Foresite Capital & 5 others	61/100
7th	GenePlanet 2008, Ljubljana (Slovenia), Series B	Genetics-based health and fitness recommendations	$34M	BlackPeak Capital, JF Investments & 2 others	60/100
8th	Dante Labs 2016, New York City (United States), Seed	Provider of whole-genome sequencing analysis for health and wellness	-	iStarter, Governo & 3 others	60/100
9th	Genomind 2009, King Of Prussia (United States), Series C	Developer of genetic tests for personalised medicines to enhance mental health treatment	$64.4M	Claritas Capital, SVB & 1 others	56/100
10th	Veritas Genetics 2014, Danvers (United States), Acquired	Provider of genetic testing products	$53.4M	Trustbridge Partners, Simcere Pharma & 6 others	55/100
339th	Fore Genomics 2021, San Diego (United States), Unfunded	Provider of genetic screening to identify risks and personalize medication	-	-	21/100